MZT Holdings, Inc., formerly known as Matritech, Inc.(Amex: MZT), announced today that it has not arranged for listing and/or registration on another national securities...
MZT Holdings, Inc., formerly known as Matritech, Inc. (Amex:MZT), announced today that its stockholders have approved: ? the sale of substantially all of the assets of the...
WALTHAM, Mass., Dec. 13 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA) today announced that it has finalized its acquisition of Matritech (AMEX:MZT). The deal was...
WALTHAM, Mass. and NEWTON, Mass., Aug. 28 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA) and Matritech, Inc. (AMEX:MZT) today announced that they have entered into an...
Matritech (Amex: MZT), a leading marketer and developer of protein-based diagnostic products for the early detection of cancer, today reported financial results for the second...
Matritech (AMEX:MZT) announced today that it will release its second quarter 2007 earnings results before market opening on July 31, 2007. The company has scheduled a conference...
Matritech?s (Amex: MZT) NMP22? BladderChek? Test was recognized by leading clinical investigators at the 2007 annual meeting of the American Urological Association (AUA) for...
Matritech (Amex: MZT), a leading developer and marketer of protein-based diagnostic products for the early detection of cancer, announced today that the NMP22? BladderChek?...
BOSTON, May 2 /PRNewswire-FirstCall/ -- Scimitar Equity Research, Inc. issues a review on Matritech, Inc. (AMEX:MZT) entitled "Revenue and Net Loss Increased, Guidance is Reaffirmed and Debt...
Matritech (Amex: MZT), a leading developer and marketer of protein-based diagnostic products for the early detection of cancer, today reported financial results for the first...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관